Higher drug exposure in women due to lower renal and hepatic clearance and body composition can increase efficacy but also toxicity, highlighting the need to reassess dosing.
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...
A study published this week found that Black Medicare beneficiaries with early-stage NSCLC remain significantly less likely than White beneficiaries to receive curative treatment, largely because of ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
A new study is shining a light on a potential way to make treatments work better for one of the deadliest forms of cancer. Researchers at Ohio University have identified a protein that could be a ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and survivorship lung health.
Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...
Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...
Lindsay Stone, 47, travelled to Dubai for a short break with her family before starting cancer treatment but the mum said she ...
The U.S. Food and Drug Administration on Thursday approved Boehringer Ingelheim's zongertinib as a first-line treatment for a rare form of non-small cell lung cancer, making it the second drug to be ...
A phase 3 global trial is enrolling previously treated locally advanced/metastatic nonsquamous NSCLC to define DATROWAY efficacy and safety at scale. IDE034 is in open-label phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results